Alnylam Pharmaceuticals
ALNY
#648
Rank
โ‚น3.708 T
Marketcap
โ‚น27,777
Share price
2.04%
Change (1 day)
-0.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company